DexCom, Inc. (dxcm)
DXCM Estimates
Public analyst price targets and consensus snapshot for DexCom, Inc.. Deeper estimate history and models are available in Vest Terminal.
| Last price | $87.73 |
| Analyst mean target | $94.48 |
| Analyst high target | $115.00 |
| Analyst low target | $79.00 |
| Upside vs mean target | 7.7% |
| Consensus recommendation | Strong Buy |
| Number of analysts | 25 |
| Forward P/E | 28.08 |
Start Free — open DXCM in Vest Terminal
Access live data, filings, ownership, and analysis for DexCom, Inc..
DexCom, Inc. FAQ
What does DexCom, Inc. (DXCM) do?
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 D…
What is DXCM's P/E ratio?
DexCom, Inc. has a trailing P/E of 35.38× based on publicly available market data.
Does DXCM pay a dividend?
Indicated dividend yield: none reported. Confirm ex-dates and payout history in Vest Terminal.
What sector is DXCM in?
DexCom, Inc. is classified in Healthcare (Medical Devices) on NMS.
What is DXCM's market capitalization?
Approximate market cap: $33.11B.
What are the main risks for DXCM?
Key risks include above-average volatility (beta 1.42), elevated valuation, among factors on this page.
What are the strengths of DXCM?
Potential positives include revenue growth of 13.1% year-over-year, earnings growth of 43.6% year-over-year.
Where can I get analyst estimates for DXCM?
Public analyst price targets and consensus for DexCom, Inc. are on the free /stocks/dxcm/estimates page. Deeper estimate history and models are available in Vest Terminal.